Search Results - "von Nieciecki, A."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Pharmacokinetics and metabolism of the anti-oestrogen droloxifene in female human subjects by John, B. A., Brodie, R. R., Baldock, G. A., McBurney, A., Chasseaud, L. F., Jank, P., von Nieciecki, A.

    Published in Xenobiotica (01-08-2002)
    “…1. Single oral doses of a solution formulation of 14 C-droloxifene citrate (141 mg) appeared to be rapidly and well absorbed in four post-menopausal female…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet by Fuchs, W S, Weiss, G, Von Nieciecki, A, Laicher, A, Gay, S, Pabst, G, Müller, M

    “…A new sustained-release theophylline formulation was especially designed for the elderly and children. Microcapsules of theophylline, administered as a…”
    Get more information
    Journal Article
  3. 3

    Urinary Excretion and Metabolism of Arbutin after Oral Administration of Arctostaphylos uvae ursi Extract as Film-Coated Tablets and Aqueous Solution in Healthy Humans by Schindler, Gemot, Patzak, Ulrich, Brinkhaus, Benno, von Nieciecki, Alexander, Wittig, Jörg, Krähmer, Nils, Glöckl, Ingmar, Veit, Markus

    Published in Journal of clinical pharmacology (01-08-2002)
    “…Bearberry leaves and preparations made from them are traditionally used for urinary tract infections. The urinary excretion of arbutin metabolites was examined…”
    Get full text
    Journal Article
  4. 4

    Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets by Walter, K, von Nieciecki, A

    Published in Arzneimittel-Forschung (2001)
    “…The relative bioavailability of diclofenac (CAS 15307-86-5) was investigated after a single administration of a multiple-unit formulation containing 75 mg…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetics of nilvadipine by von Nieciecki, A, Huber, H J, Stanislaus, F

    “…Nilvadipine is absorbed rapidly and completely and its absolute bioavailability is about 14-19% because of its high first-pass metabolism. Maximum plasma…”
    Get more information
    Journal Article
  6. 6

    Requirements for product quality of theophylline sustained-release preparations by Fuchs, W S, Hens, C, von Nieciecki, A

    Published in Arzneimittel-Forschung (01-05-1998)
    “…In consideration of the narrow therapeutic range and the pharmacology of theophylline (CAS 58-55-9), the pharmaceutic quality of sustained release theophylline…”
    Get more information
    Journal Article
  7. 7

    Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet by Fuchs, W S, Weiss, G, von Nieciecki, A, Laicher, A, Gay, S, Pabst, G, Müller, M

    Published in Arzneimittel-Forschung (01-05-1998)
    “…A new sustained release theophylline (CAS 58-55-9) formulation was especially designed for the elderly and children. Microcapsules of theophylline,…”
    Get more information
    Journal Article
  8. 8

    Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics by Witschital, K, Fuchs, W S, Heese, U, von Nieciecki, A, Laicher, A

    Published in Arzneimittel-Forschung (01-05-1998)
    “…Pharmacokinetics of two theophylline (CAS 58-55-9) sustained release preparations (T: Bronchoretard Capsules/R: Capsule formulation from the US market) were…”
    Get more information
    Journal Article
  9. 9

    Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage by Fuchs, W S, von Nieciecki, A, Pabst, G, Müller, M, Dilger, C, Gay, S, Laicher, A, Stanislaus, F

    Published in Arzneimittel-Forschung (01-05-1998)
    “…Sustained release theophylline (CAS 58-55-9) preparations may be dosed once or alternatively twice-a-day, depending on the intention of a theophylline therapy…”
    Get more information
    Journal Article
  10. 10

    In vivo verification of in vitro release specifications of a theophylline sustained-release preparation by von Nieciecki, A, Fuchs, W S, Pabst, G, Müller, M, Dilger, C, Gay, S, Laicher, A, Stanislaus, F

    Published in Arzneimittel-Forschung (01-05-1998)
    “…Especially in drugs with a narrow therapeutic range, "within product bioequivalence" i.e. "batch-to-batch bioequivalence" should be scrutinized. Therefore,…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    The effect of bile secretion on the pharmacokinetics of a theophylline sustained-release preparation by Fuchs, W S, von Nieciecki, A, Molz, K H, Popescu, G, Weil, A, Barkworth, M F, Gay, S, Laicher, A, Stanislaus, F

    Published in Arzneimittel-Forschung (01-05-1998)
    “…Bile excretion changes the physiological milieu of the duodenum, possibly resulting in enhanced absorption of a drug due to increased solubilisation. This…”
    Get more information
    Journal Article
  14. 14

    The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation by Fuchs, W S, Jakobs, R, Grunenberg, P, Weiss, G, Profitlich, T, von Nieciecki, A, Klemm, F H, Laicher, A, Stanislaus, F

    Published in Arzneimittel-Forschung (01-05-1998)
    “…In vitro dissolution studies are valuable tools to judge quality and stability of sustained release dosage forms and are often utilised to predict the in vivo…”
    Get more information
    Journal Article
  15. 15

    Pharmacokinetics and bioavailability of tamoxifen in postmenopausal healthy women by Fuchs, W S, Leary, W P, van der Meer, M J, Gay, S, Witschital, K, von Nieciecki, A

    Published in Arzneimittel-Forschung (01-04-1996)
    “…A randomised cross-over study in 24 postmenopausal women was selected to establish bioequivalence of two tamoxifen (CAS 10540-29-1) formulations. In addition,…”
    Get more information
    Journal Article
  16. 16

    Effect of gallbladder contraction induced cholagogia on the pharmacokinetic profile of a sustained-release theophylline formulation by Fuchs, W S, von Nieciecki, A, Molz, K H, Popescu, G, Weil, A, Barkworth, M F, Gay, S, Laicher, A, Stanislaus, F

    Published in Arzneimittel-Forschung (01-12-1996)
    “…Bile excretion might change the physiological milieu of the duodenum resulting in enhanced absorption of a drug due to increased solubilisation. This possible…”
    Get more information
    Journal Article